Cargando…
Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powd...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020035/ https://www.ncbi.nlm.nih.gov/pubmed/31963163 http://dx.doi.org/10.3390/nu12010231 |
_version_ | 1783497658432749568 |
---|---|
author | Ellinger, Sabine Reusch, Andreas Henckes, Lisa Ritter, Christina Zimmermann, Benno F. Ellinger, Jörg Galensa, Rudolf Stehle, Peter Helfrich, Hans-Peter |
author_facet | Ellinger, Sabine Reusch, Andreas Henckes, Lisa Ritter, Christina Zimmermann, Benno F. Ellinger, Jörg Galensa, Rudolf Stehle, Peter Helfrich, Hans-Peter |
author_sort | Ellinger, Sabine |
collection | PubMed |
description | Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (−)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (AUC(0–6h)) and incremental AUC(0–6h) were additionally calculated by using the linear trapezoidal method. After consumption of NALC and ALC, (+)-catechin and (−)-catechin were mostly not detectable in plasma, in contrast to epicatechin. For epicatechin, total AUC(0–6h) was different between both treatments, but not incremental AUC(0–6h). Most kinetic parameters were similar for both treatments, but they varied strongly between individuals. Thus, epicatechin is the main monomeric flavan-3-ol in plasma after cocoa consumption. Whether NALC should be preferred against ALC due to its higher (−)-epicatechin content remains unclear with regard to the results on incremental AUC(0–6h). Future studies should investigate epicatechin metabolites in plasma for a period up to 24 h in a larger sample size, taking into account genetic polymorphisms in epicatechin metabolism and should consider all metabolites to understand inter-individual differences after cocoa intake. |
format | Online Article Text |
id | pubmed-7020035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70200352020-03-09 Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial Ellinger, Sabine Reusch, Andreas Henckes, Lisa Ritter, Christina Zimmermann, Benno F. Ellinger, Jörg Galensa, Rudolf Stehle, Peter Helfrich, Hans-Peter Nutrients Article Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (−)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (AUC(0–6h)) and incremental AUC(0–6h) were additionally calculated by using the linear trapezoidal method. After consumption of NALC and ALC, (+)-catechin and (−)-catechin were mostly not detectable in plasma, in contrast to epicatechin. For epicatechin, total AUC(0–6h) was different between both treatments, but not incremental AUC(0–6h). Most kinetic parameters were similar for both treatments, but they varied strongly between individuals. Thus, epicatechin is the main monomeric flavan-3-ol in plasma after cocoa consumption. Whether NALC should be preferred against ALC due to its higher (−)-epicatechin content remains unclear with regard to the results on incremental AUC(0–6h). Future studies should investigate epicatechin metabolites in plasma for a period up to 24 h in a larger sample size, taking into account genetic polymorphisms in epicatechin metabolism and should consider all metabolites to understand inter-individual differences after cocoa intake. MDPI 2020-01-16 /pmc/articles/PMC7020035/ /pubmed/31963163 http://dx.doi.org/10.3390/nu12010231 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ellinger, Sabine Reusch, Andreas Henckes, Lisa Ritter, Christina Zimmermann, Benno F. Ellinger, Jörg Galensa, Rudolf Stehle, Peter Helfrich, Hans-Peter Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title | Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title_full | Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title_fullStr | Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title_full_unstemmed | Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title_short | Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial |
title_sort | low plasma appearance of (+)-catechin and (−)-catechin compared with epicatechin after consumption of beverages prepared from nonalkalized or alkalized cocoa—a randomized, double-blind trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020035/ https://www.ncbi.nlm.nih.gov/pubmed/31963163 http://dx.doi.org/10.3390/nu12010231 |
work_keys_str_mv | AT ellingersabine lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT reuschandreas lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT henckeslisa lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT ritterchristina lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT zimmermannbennof lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT ellingerjorg lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT galensarudolf lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT stehlepeter lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial AT helfrichhanspeter lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial |